2020
DOI: 10.5455/njppp.2020.10.07195202026072020
|View full text |Cite
|
Sign up to set email alerts
|

Management perspective of COVID-19 patients from L1 till L3 level hospital: An observational study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

2
0
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(5 citation statements)
references
References 0 publications
2
0
0
Order By: Relevance
“…ceftriaxone (19.64%), and injection meropenem (8.92%). Similar to our results numerous research workers have shown azithromycin and hydroxychloroquine to be most frequently prescribed in COVID-19 patients [12,[22][23][24].…”
Section: Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…ceftriaxone (19.64%), and injection meropenem (8.92%). Similar to our results numerous research workers have shown azithromycin and hydroxychloroquine to be most frequently prescribed in COVID-19 patients [12,[22][23][24].…”
Section: Discussionsupporting
confidence: 92%
“…The majority of patients were having education below matriculation (50%). Similar to our observations, other studies have also documented males to be predominantly affected with COVID-19 [12,13]. Perhaps, the reason for this may be due to increased mobility among males compared to females who mostly remain confined to their home in rural setup.…”
Section: Discussionsupporting
confidence: 90%
“…In our study, 29.3% patient had comorbidities and of them 52.3% died. Mean age group in our study was 45.43 y and the predominant age group in Thakur et al was 31-51 in about 50% cases and similar finding was seen in S N Hasan et al [18]. The both wave cumulative mortality in our study was around 16% and only Teli J G et al [17] documented the mortality around 4.3%.…”
Section: Discussionsupporting
confidence: 82%
“…The spectrum clinical features included fever (29-84%), headache (16-50%), cough (32-59%), asthenia (16-70.3%), myalgia (16-58%), shortness of breath (10-27%), gastrointestinal symptoms (0.06-14%), loss of smell and taste (33-72%) and rhinorrhoea (6-16%). The clinical spectrum in our study is in accordance [16,17,18]. Only Teli J G et al documented the laboratory findings among death cases and had elevated inflammatory markers in all the subjects like Ferritin, CRP, D-dimer and LDH.…”
Section: Discussionsupporting
confidence: 80%
See 1 more Smart Citation